Health advertising in the digital age plays a pivotal role in informing patients about medications, treatments, and care options. This sector's growth has been meteoric, becoming the largest and fastest-growing vertical in digital advertising. However, as beneficial as this innovation is, it
In recent months, patients using GLP-1 weight-loss medications such as Wegovy and Zepbound have faced financial hurdles due to significant changes in insurance coverage. Insurers, particularly Independence Blue Cross (IBX), have opted to reduce or completely drop coverage for obesity treatment,
Healthcare workers (HWs) in North Central Nigeria face a heightened risk of contracting tuberculosis (TB), particularly in settings where they work with people living with HIV (PLHIV). The significant risk stems from the close interaction between HWs and their HIV-infected patients, making them
The American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium of 2025, held in San Francisco, California, featured a keynote presentation by Dr. William Dahut, Chief Scientific Officer for the American Cancer Society (ACS). The topic of his presentation was the integration
The fierce competition surrounding the management of Georgia's Medicaid contract has sparked significant controversy and debate. This multi-billion-dollar public procurement involves several insurers vying for the contract awarded by Governor Brian Kemp’s administration to oversee healthcare f
Jefferson City is grappling with a significant financial dilemma as it seeks to bridge a $750,000 shortfall in its self-funded health insurance plan for fiscal year 2024. The Jefferson City Council recently faced a critical decision to cover this deficit, with various funding strategies being
